Humulin R Injection, Solution
Product Images NDC 50090-0353

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Humulin R (NDC 50090-0353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Humulin R100 Uspi 1v1)

A line graph depicting the glucose infusion rate (mg/min/kg) over time (hours) following administration of Humulin R (0.3 U/kg). The curve shows a rise in glucose infusion rate peaking around 2 hours, then gradually declining over the next several hours up to 14 hours.*

FDA Label Image

Figure (Humulin R100 Ifu 1v3)

Label image of HUMULIN R insulin human injection, solution, 100 units per mL, showing a clear vial with a black protective cap and rubber stopper. The label includes the brand name Humulin R and strength information. Manufactured by A-S Medication Solutions.*

FDA Label Image

Figure (Humulin R100 Ifu 16v1)

An instructional diagram of an insulin syringe illustrating its parts, including the needle shield, needle, plunger tip, syringe body with unit markings, and plunger. The image highlights an example dose of 20 units shown at the plunger tip, with a zoomed-in view of the scale on the syringe body at that dose level.*

FDA Label Image

Figure (Humulin R100 Ifu 3v1)

An instructional illustration showing a hand holding a vial of Humulin R injection solution. The image demonstrates lifting or removing a protective cap from the vial, indicated by an upward arrow. The vial appears clear with a visible neck and opening.*

FDA Label Image

Figure (Humulin R100 Ifu 4v1)

An instructional line drawing showing a pair of hands holding a vial. One hand supports the vial from below while the other hand is removing a cap or seal from the top of the vial. This image likely illustrates proper vial handling or preparation steps for injection.*

FDA Label Image

Figure (Humulin R100 Ifu 5v1)

An instructional illustration demonstrating the proper technique for drawing a solution into a syringe. The left side shows hands holding a syringe with an arrow indicating downward motion, and the right side is a close-up of the syringe barrel with measurement markings visible.*

FDA Label Image

Figure (Humulin R100 Ifu 6v1)

An instructional illustration showing two hands, one holding a small vial and the other holding a syringe with a needle. An arrow indicates the syringe needle being inserted into the vial, suggesting the preparation step for drawing medication.*

FDA Label Image

Figure (Humulin R100 Ifu 7v1)

An instructional diagram showing hands preparing a syringe for injection. One hand holds a vial or container, and the other hand is drawing liquid into the syringe, indicated by an arrow pointing to the plunger being pulled back.*

FDA Label Image

Figure (Humulin R100 Ifu 8v1)

An instructional illustration showing a hand holding a vial of medication upside down while drawing solution into a syringe. An inset image shows a syringe with a 40-unit maximum scale and markings at 10, 20, and 30 units.*

FDA Label Image

Figure (Humulin R100 Ifu 9v1)

An instructional black-and-white line drawing showing a person holding a vial and syringe. One hand holds the vial upside down while the other hand holds the syringe with the needle inserted into the vial, illustrating the process of drawing medication from the vial into the syringe.*

FDA Label Image

Figure (Humulin R100 Ifu 10v1)

An instructional illustration showing the process of drawing medication from a vial into a syringe. A hand holds the vial upside down while the other hand pulls back the syringe plunger to draw the liquid. The syringe scale, marked up to 40 units, is shown in detail to the right.*

FDA Label Image

Figure (Humulin R100 Ifu 11v1)

An instructional illustration showing a hand holding a syringe with an injection needle being inserted into the forearm. The other hand holds a vial, positioned near the injection site. An arrow indicates the direction of injection into the forearm.*

FDA Label Image

Figure (Humulin R100 Ifu 12v2)

An instructional diagram showing common injection sites for HUMULIN R (insulin human) injection, solution. The front view highlights the abdomen and upper thigh areas, and the back view highlights the lower back near the hip regions for injection placement.*

FDA Label Image

Figure (Humulin R100 Ifu 13v1)

An instructional illustration showing a person administering an injection with a syringe into the abdomen area, indicated by an arrow pointing to the injection site below the waistline of pants. The image demonstrates the injection technique for a subcutaneous injection.*

FDA Label Image

Figure (Humulin R100 Ifu 14v1)

An instructional illustration showing an injection being administered into the abdomen. A hand pinches the skin around the injection site, while another hand inserts a syringe needle at a perpendicular angle into the abdominal area, near the belt line.*

FDA Label Image

Figure (Humulin R100 Ifu 15v1)

An instructional illustration showing a person injecting medication into the abdomen using a syringe. The image depicts the hand holding the syringe with an arrow indicating the direction of injection into the abdominal area.*

FDA Label Image

Figure (Humulin R100 Qr)

FDA Label Image

Label Image (Lbl500900353)

Label for Humulin R insulin human injection, 100 units per mL, 10 mL vial. It includes the NDC 50090-0353-0 and product number 2319-0. The label specifies refrigeration requirements and the labeler as A-S Medication Solutions, Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.